Mastectomy plus reconstruction has highest rate of complication,...
In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had...
MD Anderson Cancer Center and Adaptimmune form strategic...
Adaptimmune Therapeutics and The University of Texas MD Anderson Cancer Center announced today they have entered into a multi-year...
Melanoma tumors use interferon-gamma mutations to fight...
Melanoma tumors use genetic mutations in a prominent immune response pathway to resist the immunotherapy ipilimumab, researchers from...
Rogers Award for Excellence in Prevention awarded to Maher...
Maher Karam-Hage, M.D., professor, Behavioral Science and Psychiatry, and associate medical director, Tobacco Treatment Program, is...
MD Anderson and Rice University welcome Vice President...
The University of Texas MD Anderson Cancer Center is pleased to welcome Vice President Joe Biden to Houston and the historic site...
MD Anderson receives $19 million in CPRIT funding for...
The University of Texas MD Anderson Cancer Center was awarded $19 million this week from the Cancer Prevention and Research Institute...
Combination therapy shows promise for chronic myeloid...
A study in mice combining two inhibitor drugs for treatment of chronic myeloid leukemia (CML) has revealed potential for not only...